Show simple item record

Drug membrane transport enhancement using high energy drug polyvinylpyrrolidone (PVP) co-precipitates

dc.contributor.authorCorrigan, O. I.en_US
dc.contributor.authorFarvar, M. A.en_US
dc.contributor.authorHiguchi, William I.en_US
dc.date.accessioned2006-04-07T17:24:59Z
dc.date.available2006-04-07T17:24:59Z
dc.date.issued1980-05en_US
dc.identifier.citationCorrigan, O. I., Farvar, M. A., Higuchi, W. I. (1980/05)."Drug membrane transport enhancement using high energy drug polyvinylpyrrolidone (PVP) co-precipitates." International Journal of Pharmaceutics 5(3): 229-238. <http://hdl.handle.net/2027.42/23253>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6T7W-4772KDJ-7/2/24c237b301bc51f6d5892b7e21abb5faen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/23253
dc.description.abstractDissolution rate data obtained with sulfathiazole-povidone(PVP) co-precipitates and hydrocortisone-povidone co-precipitates were compared to cellophane membrane diffusion data obtained with the co-precipitates. The hypothesis, that the rate-limiting drug phases in the co-precipitate dissolution experiments were high energy amorphous phases of the drug, was tested. In regions of the dissolution rate studies where the carrier effects due to the PVP-drug complexes were small, the dissolution rates for the two PVP-drug systems agreed well with the results of the membrane diffusion experiments. The normalized fluxes were found to be about 3.5 for the high energy phase of sulfathiazole and 14-18 for that of hydrocortisone.en_US
dc.format.extent888654 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleDrug membrane transport enhancement using high energy drug polyvinylpyrrolidone (PVP) co-precipitatesen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, Ann Arbor, Mich. 48109, U.S.A.en_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, Ann Arbor, Mich. 48109, U.S.A.en_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, Ann Arbor, Mich. 48109, U.S.A.en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/23253/1/0000186.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0378-5173(80)90130-1en_US
dc.identifier.sourceInternational Journal of Pharmaceuticsen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.